NSW Cancer Research Education State-wide Seminar Series October 2024
The NSW Regional Cancer Research Network, in collaboration with Sydney Cancer Partners and Maridulu Budyari Gumal (SPHERE) Cancer CAG, will be hosting the 2024 NSW Cancer Research Education State-wide Seminar Series.
These online seminars will be held on the 3rd Tuesday of each month.
Molecular Tumour Board. The biomarker boom in non-squamous, non-small cell lung cancer. Efficient testing and personalised treatment.
Three cases will be presented exemplifying the standard of care for molecular testing in NSCLC, and impact this may have on the therapeutic pathway and survival. Cases may have accessed liquid biopsy to expedite diagnosis, monitor disease control and/or explore the underpinnings of drug resistance. Liquid biopsy is an evolving and complementary tool to tissue in NSCLC. The therapeutic landscape for oncogene driven lung cancers has rapidly evolved in recent years, and ever changing. A reliable molecular diagnosis is key.
Speakers
Dr Malinda Itchins. Medical Oncologist, Royal North Shore Hospital & Chris O’Brien Lifehouse
A/Prof Steven Kao. Medical Oncologist, Chris O’Brien Lifehouse
